ArticleFrontiers in pharmacology2023

Pexidartinib synergize PD-1 antibody through inhibiting treg infiltration by reducing TAM-derived CCL22 in lung adenocarcinoma.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.